Mogamulizumab versus investigator choice in relapsed/refractory adult T-cell leukemia/lymphoma: all four one or none for all? [electronic resource]
Producer: 20191230Description: 864-867 p. digitalISSN:- 1592-8721
No physical items for this record
Publication Type: Editorial; Comment
There are no comments on this title.
Log in to your account to post a comment.